Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Prevent Osteoporotic Fractures with a Fracture Liaison Service

Micah Yu, MD, Anna Lafian, DO, & Christina Downey, MD  |  Issue: May 2019  |  May 18, 2019

alice-photo / shutterstock.com

alice-photo / shutterstock.com

Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk?

Unfortunately, this happens every day with osteoporosis and fractures in health systems around the world. Just as the link between untreated hypertension and myocardial infarction is undeniable, so is the knowledge that osteoporosis leads to fractures. Given its high prevalence, the potential for high costs passed on to patients and the health system overall, and the availability of drugs to treat and prevent fractures, osteoporosis should be considered an enormous public health concern.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the U.S. and Europe, it is estimated that approximately 30% of postmenopausal women have osteoporosis. Forty percent of these women will suffer at least one fragility fracture in their lifetime, and having an initial fragility fracture increases the risk of sustaining a new fracture by about 85%.1

Despite these astounding figures, diagnosis and treatment of osteoporosis remains low among physicians worldwide. As of 2016, the percentage of postmenopausal women being screened for osteoporosis in the U.S. was 41.9%, well below the national average for breast cancer screening (72.7%) and beta blocker treatment after a myocardial infarction (84.4%).2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Even after patients are admitted and treated for non-traumatic fragility fractures, the osteoporosis management rate remains very low. One retrospective study found that treatment was prescribed in only 44% of cases after a vertebral fracture and only 21% of cases after a proximal femur fracture.3

Rheumatology Initiatives in Fracture Liaison Services

The abysmal rate of treatment after the sentinel event of first osteoporotic fracture makes this an area ripe for improvement. A Fracture Liaison Service (FLS) is a means to improve secondary prevention of osteoporotic fractures. The National Osteoporosis Foundation (NOF) recognizes the FLS as a means to improve outcomes related to secondary prevention of fractures.4

Geisinger Health System (GHS) was one of the first health systems to develop an FLS in the U.S. The GHS High Risk Osteoporosis Clinic was developed in 1996. It is a program headed by the Division of Rheumatology and uses osteoporosis management guidelines to help improve osteoporosis diagnosis and treatment.5 GHS was able to decrease hip fracture rates, increase the number of patients who receive a dual-energy X-ray absorptiometry (DXA) scan and increase the number of patients who received treatment.5

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:FracturesOsteoporosisosteoporosis treatmentsosteoporotic fracture rates

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Reading Rheum

    May 1, 2009

    Handpicked Reviews of Contemporary Literature

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences